Skip to main content
FDA approves first PARP inhibitor for early BRCA+ breast cancer
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA approves first PARP inhibitor for early BRCA+ breast cancer
User login
Username
Password
Reset your password
Concept
Lead
score
Breast Cancer
1
1
Ovarian Cancer
0
1
Breast
0
0.67
Poly ADP-Ribose Polymerase (PARP) Inhibitor
0
1
Cancer
0
0.42
Food and Drug Administration (FDA)
0
0.42
BRCA
0
0.08
Chemotherapy
0
0.08
Clinical Guidelines
0
0.08
Clinical Research
0
0.08
Europe
0
0.08
Medical Oncology
0
0.08
Specialty
Lead
score
Hematology-Oncology
1
1
Ob/Gyn & Women's Health
0
1
Internal Medicine
0
1
Pharmacist
0
0.94
Edit Tags